Emilie Laurent
Lyon, 69008, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor.
Journal: NPJ vaccines
Published: March 13, 2025
Host-targeted repurposed diltiazem enhances the antiviral activity of direct acting antivirals against Influenza A virus and SARS-CoV-2.
Journal: Antiviral research
Published: November 30, 2024
Author Correction: Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.
Journal: NPJ vaccines
Published: July 09, 2024
Interactions Between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human Nasal Epithelium.
Journal: The Journal of infectious diseases
Published: June 02, 2022
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
Journal: The Journal of experimental medicine
Published: March 22, 2022
Avian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac®.
Journal: Vaccines
Published: September 13, 2021
Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies.
Journal: Cancer immunology, immunotherapy : CII
Published: June 01, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026